The Biosphere

Biosphere is a private industrial biotechnology and biomanufacturing company developing UV-enabled bioreactor systems intended to replace traditional steam-sterilized fermentation infrastructure. The company positions its technology as a lower-cost, faster, and simpler approach for commercial-scale fermentation, and offers both proprietary reactor systems and manufacturing services to partners. Biosphere focuses on enabling scale-up and production of bioproducts across markets including medicines, enzymes, proteins, foods, chemicals, and materials rather than advancing a therapeutic drug pipeline of its own. The business appears to operate as a platform and manufacturing infrastructure company rather than a therapeutics developer. Public materials indicate the company was founded in 2022 by Brian Heligman and Arye Lipman and is backed by Lowercarbon Capital, VXI Capital, Founders Fund, and GS Futures.